蛋白質定序市場規模、佔有率、成長分析、按產品、按應用、按最終用戶、按地區 - 行業預測，2025-2032 年

2023年蛋白質定序市場規模為13.4億美元，從2024年的13.9億美元成長到2032年的17.5億美元，複合年成長率預計為3.5%。

由於其在從頭定序（透過質譜解碼氨基酸序列）中的重要作用，蛋白質定序市場正在經歷強勁成長。這種高通量蛋白質體學技術在基於目標的藥物發現中越來越受到關注，這在很大程度上是由於生物技術和製藥公司專注於在已開發和新興市場開發標靶治療。蛋白質體學研究資金的增加反映了藥物開發中對蛋白質生物標記物不斷成長的需求，進一步加強了該領域的發展。隨著製藥和生物技術行業擴大採用基於目標的藥物設計，該市場預計將繼續成長。此外，蛋白質定序技術的進步和正在進行的基因改造生物研究可能會增強基因工程的應用並推動該行業的未來成長。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 監管環境
• 專利分析
• 案例研究

蛋白質定序市場規模：依產品/服務分類

• 市場概況
• 蛋白質定序產品
  • 試劑/耗材
  • 裝置
  • 質譜分析
  • 艾德曼劣化
  • 軟體
• 蛋白質定序服務
  • 樣品製備服務
  • 定序服務
  • 資料分析服務

蛋白質定序市場規模：依應用分類

• 市場概況
• 生物標記發現
• 蛋白質工程研究
• 生物製藥
• 其他
  • 結構生物學
  • 藥物發現

蛋白質定序市場規模：依最終用戶分類

• 市場概況
• 製藥和生物技術公司
• 研究中心
• 學術機構
• 其他
  • 合約研究組織（CRO）
  • 診斷實驗室

蛋白質定序市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2022-2024）

主要企業簡介

• Thermo Fisher Scientific Inc.（USA）
• Agilent Technologies, Inc.（USA）
• Bioinformatics Solutions Inc.（Canada）
• Shimadzu Corporation（Japan）
• Waters Corporation（USA）
• Bruker Corporation（USA）
• Danaher Corporation（USA）
• PerkinElmer, Inc.（USA）
• Charles River Laboratories International, Inc.（USA）
• QIAGEN NV（Netherlands）
• Merck KGaA（Germany）
• GenScript Biotech Corporation（China）
• Creative Proteomics（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Promega Corporation（USA）
• Pacific Biosciences of California, Inc.（USA）
• Oxford Nanopore Technologies Ltd.（UK）
• Illumina, Inc.（USA）
• Becton, Dickinson and Company（USA）
• Eurofins Scientific（Luxembourg）

結論和建議

Protein Sequencing Market size was valued at USD 1.34 Billion in 2023 and is poised to grow from USD 1.39 Billion in 2024 to USD 1.75 Billion by 2032, growing at a CAGR of 3.5% during the forecast period (2025-2032).

The protein sequencing market is experiencing robust growth, driven by its vital role in de novo sequencing, which deciphers amino acid sequences via mass spectrometry. This high-throughput proteomic technique has gained traction in target-based drug discovery, significantly influenced by the intensified focus of biotechnology and pharmaceutical companies on developing targeted therapies across developed and emerging markets. Increased funding for proteomics research further bolsters this sector, reflecting a heightened demand for protein biomarkers in drug development. As the pharmaceutical and biotechnology industries increasingly adopt target-based medication design, the market is poised for continued expansion. Moreover, advancements in protein sequencing technology and ongoing research into genetically modified organisms will likely enhance its application in genetic engineering, propelling future growth in the industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Protein Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Protein Sequencing Market Segmental Analysis

Global Protein Sequencing Market is segmented by product, application, end-user and region. Based on product, the market is segmented into protein sequencing products and protein sequencing services. Based on application, the market is segmented into biomarker discovery, protein engineering studies, biotherapeutics and others. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, research centers, academic institutions and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Protein Sequencing Market

The Protein Sequencing market is set to experience significant growth driven by several technological advancements. Key among these is the enhancement of clinical mass spectrometry and analytical techniques, which are expected to facilitate more accurate and efficient protein analysis. Additionally, the increasing financial support from both public and private sectors for proteome research is anticipated to significantly contribute to the expansion of this market. This combination of improved technologies and bolstered funding will likely create a favorable environment for innovation and development within the protein sequencing sector, thus propelling market growth throughout the forecast period.

Restraints in the Protein Sequencing Market

One of the significant challenges hindering the growth of the Protein Sequencing market is the high cost associated with the necessary infrastructure. This financial burden poses a considerable barrier to market expansion during the forecast period. Furthermore, the demand for highly skilled researchers and laboratory personnel also restricts growth potential, as specialized expertise is essential for effective protein sequencing. Additionally, the complexities involved in generating pure protein samples contribute to the overall limitations facing the market. Collectively, these factors create a restrictive environment that may slow down advancements and innovation within the Protein Sequencing landscape.

Market Trends of the Protein Sequencing Market

The protein sequencing market is experiencing significant growth driven by advancements in protein engineering, particularly the incorporation of unnatural amino acids (uAA). This trend enables site-specific conjugation of functional moieties, enhancing the effectiveness of therapeutic drugs, including antibodies and vaccines. As bioformulations dominate the pharmaceutical landscape, the demand for precise and efficient protein characterization tools is surging. Furthermore, innovations in post-translational engineering and strain development are accelerating biopharmaceutical approvals, making the market more dynamic. With a focus on developing better-defined protein products, the protein sequencing market is poised for substantial expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Protein Sequencing Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Protein Sequencing Products
  • Reagents & Consumables
  • Instruments
  • Mass Spectrometry
  • Edman Degradation
  • Software
• Protein Sequencing Services
  • Sample Preparation Services
  • Sequencing Services
  • Data Analysis Services

Global Protein Sequencing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Biomarker Discovery
• Protein Engineering Studies
• Biotherapeutics
• Others
  • Structural Biology
  • Drug Discovery

Global Protein Sequencing Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Research Centers
• Academic Institutions
• Others
  • Contract Research Organizations (CROs)
  • Diagnostic Laboratories

Global Protein Sequencing Market Size & CAGR (2025-2032)

• North America (Product & Service, Application, End-User)
  • US
  • Canada
• Europe (Product & Service, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioinformatics Solutions Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Proteomics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations